These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 23564797)

  • 1. Clinical significance of galectin-7 in epithelial ovarian cancer.
    Kim HJ; Jeon HK; Lee JK; Sung CO; Do IG; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
    Anticancer Res; 2013 Apr; 33(4):1555-61. PubMed ID: 23564797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippo pathway effector Yap is an ovarian cancer oncogene.
    Hall CA; Wang R; Miao J; Oliva E; Shen X; Wheeler T; Hilsenbeck SG; Orsulic S; Goode S
    Cancer Res; 2010 Nov; 70(21):8517-25. PubMed ID: 20947521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Intracellular Galectin-8 and -9 in Endometrial Cancer.
    Beyer S; Wehrmann M; Meister S; Trillsch F; Ganster F; Schmoeckel E; Corradini S; Mahner S; Jeschke U; Kessler M; Burges A; Kolben T
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical significance of Gal-3 and NFκB pathway-related factors in epithelial ovarian carcinoma.
    Luk HM; Wang DY; Xie LL; Liu XY; Xu GC; Lu HW
    Int J Clin Exp Pathol; 2020; 13(5):1197-1205. PubMed ID: 32509095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrative model for recurrence in ovarian cancer.
    Laios A; O'Toole SA; Flavin R; Martin C; Ring M; Gleeson N; D'Arcy T; McGuinness EP; Sheils O; Sheppard BL; O' Leary JJ
    Mol Cancer; 2008 Jan; 7():8. PubMed ID: 18211683
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-translational regulation of the cleaved fragment of Par-4 in ovarian and endometrial cancer cells.
    Brasseur K; Fabi F; Adam P; Parent S; Lessard L; Asselin E
    Oncotarget; 2016 Jun; 7(24):36971-36987. PubMed ID: 27175591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and functions of galectin-7 in ovarian cancer.
    Labrie M; Vladoiu MC; Grosset AA; Gaboury L; St-Pierre Y
    Oncotarget; 2014 Sep; 5(17):7705-21. PubMed ID: 25277199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer.
    Zhang P; Zhang P; Shi B; Zhou M; Jiang H; Zhang H; Pan X; Gao H; Sun H; Li Z
    Cell Death Dis; 2014 Jan; 5(1):e991. PubMed ID: 24407244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell transcriptome profiling of the stepwise progression of head and neck cancer.
    Choi JH; Lee BS; Jang JY; Lee YS; Kim HJ; Roh J; Shin YS; Woo HG; Kim CH
    Nat Commun; 2023 Feb; 14(1):1055. PubMed ID: 36828832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectins as pivotal components in oncogenesis and immune exclusion in human malignancies.
    Kapetanakis NI; Busson P
    Front Immunol; 2023; 14():1145268. PubMed ID: 36817445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of galectins‑1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer (Review).
    Mielczarek-Palacz A; Kondera-Anasz Z; Smycz-Kubańska M; Englisz A; Janusz A; Królewska-Daszczyńska P; Wendlocha D
    Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35293602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functions and Inhibition of Galectin-7, an Emerging Target in Cellular Pathophysiology.
    Sewgobind NV; Albers S; Pieters RJ
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure.
    Laderach DJ; Compagno D
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectins and Ovarian Cancer.
    Shimada C; Xu R; Al-Alem L; Stasenko M; Spriggs DR; Rueda BR
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding and Targeting Apoptotic Pathways in Ovarian Cancer.
    Al-Alem LF; Baker AT; Pandya UM; Eisenhauer EL; Rueda BR
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31652965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Galectins in Tumor Progression, Treatment and Prognosis of Gynecological Cancers.
    Chetry M; Thapa S; Hu X; Song Y; Zhang J; Zhu H; Zhu X
    J Cancer; 2018; 9(24):4742-4755. PubMed ID: 30588260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSP40 co-chaperone protein Tid1 suppresses metastasis of head and neck cancer by inhibiting Galectin-7-TCF3-MMP9 axis signaling.
    Chen YS; Chang CW; Tsay YG; Huang LY; Wu YC; Cheng LH; Yang CC; Wu CH; Teo WH; Hung KF; Huang CY; Lee TC; Lo JF
    Theranostics; 2018; 8(14):3841-3855. PubMed ID: 30083263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of galectin-7 in vulvar lichen sclerosus and its effect on dermal fibroblasts.
    Zhao Y; Zhao S; Li H; Qin X; Wu X
    Oncol Lett; 2018 Aug; 16(2):2559-2564. PubMed ID: 30013650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9.
    Schulz H; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U; Schmoeckel E
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-7 in Epithelial Homeostasis and Carcinomas.
    Advedissian T; Deshayes F; Viguier M
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.